These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34353648)

  • 21. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.
    O'Malley SS; Garbutt JC; Gastfriend DR; Dong Q; Kranzler HR
    J Clin Psychopharmacol; 2007 Oct; 27(5):507-12. PubMed ID: 17873686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
    Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
    Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.
    Garbutt JC; Kranzler HR; O'Malley SS; Gastfriend DR; Pettinati HM; Silverman BL; Loewy JW; Ehrich EW;
    JAMA; 2005 Apr; 293(13):1617-25. PubMed ID: 15811981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does family history of alcoholism moderate naltrexone's effects on alcohol use?
    Capone C; Kahler CW; Swift RM; O'Malley SS
    J Stud Alcohol Drugs; 2011 Jan; 72(1):135-40. PubMed ID: 21138720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients.
    Lapham S; Forman R; Alexander M; Illeperuma A; Bohn MJ
    J Subst Abuse Treat; 2009 Jan; 36(1):1-6. PubMed ID: 18775624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts.
    Finigan MW; Perkins T; Zold-Kilbourn P; Parks J; Stringer M
    J Subst Abuse Treat; 2011 Oct; 41(3):288-93. PubMed ID: 21696912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A delayed injection-site reaction in a patient receiving extended-release naltrexone.
    Ahamad K; Korthuis PT; Lum PJ; Johnson C; Wood E
    Subst Abus; 2016; 37(2):278-80. PubMed ID: 26820699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aversion to injection limits acceptability of extended-release naltrexone among homeless, alcohol-dependent patients.
    Friedmann PD; Mello D; Lonergan S; Bourgault C; O'Toole TP
    Subst Abus; 2013; 34(2):94-6. PubMed ID: 23577900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of naltrexone in the management of alcohol dependence.
    Garbutt JC
    Curr Pharm Des; 2010; 16(19):2091-7. PubMed ID: 20482515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial.
    Edelman EJ; Moore BA; Holt SR; Hansen N; Kyriakides TC; Virata M; Brown ST; Justice AC; Bryant KJ; Fiellin DA; Fiellin LE
    AIDS Behav; 2019 Jan; 23(1):211-221. PubMed ID: 30073637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Holidays, triggers, and willpower--is there a role for medications? A commentary on "The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients".
    Rosenbloom DL
    J Subst Abuse Treat; 2009 Jan; 36(1):7. PubMed ID: 19038694
    [No Abstract]   [Full Text] [Related]  

  • 32. Naltrexone for alcohol dependence: a randomized controlled trial.
    Morris PL; Hopwood M; Whelan G; Gardiner J; Drummond E
    Addiction; 2001 Nov; 96(11):1565-73. PubMed ID: 11784454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.
    Soyka M; Rösner S
    Curr Drug Abuse Rev; 2008 Nov; 1(3):280-91. PubMed ID: 19630726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A synopsis of the pharmacological rationale, properties and therapeutic effects of depot preparations of naltrexone for treating alcohol dependence.
    Johnson BA
    Expert Opin Pharmacother; 2006 Jun; 7(8):1065-73. PubMed ID: 16722816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naltrexone improves outcome of a controlled drinking program.
    Rubio G; Manzanares J; Lopez-Muñoz F; Alamo C; Ponce G; Jimenez-Arriero MA; Palomo T
    J Subst Abuse Treat; 2002 Dec; 23(4):361-6. PubMed ID: 12495798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy for Adults with Alcohol Use Disorder.
    Salisbury-Afshar E
    Am Fam Physician; 2016 Jul; 94(2):155-7. PubMed ID: 27419333
    [No Abstract]   [Full Text] [Related]  

  • 38. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.
    Chick J; Anton R; Checinski K; Croop R; Drummond DC; Farmer R; Labriola D; Marshall J; Moncrieff J; Morgan MY; Peters T; Ritson B
    Alcohol Alcohol; 2000; 35(6):587-93. PubMed ID: 11093966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New pharmacotherapies for alcohol dependence.
    Graham R; Wodak AD; Whelan G
    Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
    Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
    Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.